A detailed history of Slate Stone Wealth, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Slate Stone Wealth, LLC holds 2,294 shares of DXCM stock, worth $165,718. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,294
Previous 1,773 29.39%
Holding current value
$165,718
Previous $246,000 5.69%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$110.31 - $140.45 $57,471 - $73,174
521 Added 29.39%
2,294 $260,000
Q1 2024

Apr 26, 2024

BUY
$114.22 - $140.1 $202,512 - $248,397
1,773 New
1,773 $246,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.9B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Slate Stone Wealth, LLC Portfolio

Follow Slate Stone Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Slate Stone Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Slate Stone Wealth, LLC with notifications on news.